XM n’offre pas ses services aux résidents des États-Unis d’Amérique.

XM n’offre pas ses services aux résidents des États-Unis d’Amérique.
L
L

LaboratoryCorporation

Actualités

Reuters - Il y a 1 mois

U.S. Avidity Biosciences, Broadcom, Cara Therapeutics

U.S. RESEARCH ROUNDUP-Avidity Biosciences, Broadcom, Cara Therapeutics June 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Avidity Biosciences, Broadcom and Cara Therapeutics, on Thursday. HIGHLIGHTS * Avidity Biosciences Inc RNA.O : Leerink Partners raises target price to $56 from $38 * Broadcom Inc AVGO.O : TD Cowen raises target price to $1,750 from $1,500 * Cara Therapeutics Inc CARA.O : Canaccord Genuity cut
B
B
C
C
G
M
C
A
D
I
L
Reuters - Il y a 1 mois

U.S. Abbvie, Lionsgate Studios, UnitedHealth Group

U.S. RESEARCH ROUNDUP-Abbvie, Lionsgate Studios, UnitedHealth Group June 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Abbvie, Lionsgate Studios and UnitedHealth Group, on Wednesday. HIGHLIGHTS * Abbvie Inc ABBV.N : HSBC raises to buy from hold * Crowdstrike Holdings Inc CRWD.O : BTIG cuts target price to $402 from $432 * Lionsgate Studios LION.O : Seaport Research Partners initiates coverage with neutral rating
A
S
A
I
L
P
Reuters - Il y a 2 mois

Sherlock Bio evaluates over-the-counter rapid test for STIs, aims launch in 2025

Sherlock Bio evaluates over-the-counter rapid test for STIs, aims launch in 2025 By Bhanvi Satija May 30 (Reuters) - Sherlock Bio said on Thursday it had begun a trial of its over-the-counter rapid test for detecting sexually transmitted infections (STI) such as chlamydia and gonorrhea, and aims to launch it by mid-2025. The Massachusetts-based startup expects to become the first to launch a prescription-free rapid test for the infections, which affected 2.3 million people in the United States i
L
Reuters - Il y a 2 mois

U.S. Elevance Health, Wesco International, WW Grainger

U.S. RESEARCH ROUNDUP-Elevance Health, Wesco International, WW Grainger May 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.listed companies including Elevance Health, Wesco International and WW Grainger, on Thursday. HIGHLIGHTS * Cigna Group CI.N : JP Morgan raises target price to $435 from $432 * Elevance Health Inc ELV.N : JP Morgan raises target price to $631 from $628 * Uipath Inc PATH.N : TD Cowen cuts to hold from buy * Wesco Internati
A
C
C
E
F
S
A
E
H
W
A
L
U
Reuters - Il y a 2 mois

Some of the biggest splits in Corporate America

FACTBOX-Some of the biggest splits in Corporate America Adds DuPont, Masimo Corp, Lionsgate, Citigroup, Edwards Lifesciences, Western Digital and AT&T ; Updates Labcorp, 3M, Kellogg, J&J and General Electric Co May 23 (Reuters) - Chemical maker DuPont DD.N has become the latest multinational to break up its business, announcing a plan to split the firm into three publicly traded companies.
A
C
E
K
P
W
D
C
L
O
Reuters - Il y a 2 mois

Laboratory Corporation Of America Holdings Files For Debt Shelf

BRIEF-Laboratory Corporation Of America Holdings Files For Debt Shelf May 17 (Reuters) - Laboratory Corporation of America Holdings LH.N : LABORATORY CORPORATION OF AMERICA HOLDINGS FILES FOR DEBT SHELF; SIZE NOT DISCLOSED- SEC FILING LABORATORY CORPORATION OF AMERICA HOLDINGS: UNIT LABCORP HOLDINGS INC FILES FOR MIXED SHELF ; SIZE NOT DISCLOSED-SE
L
Reuters - Il y a 2 mois

U.S. STOCKS Cracker Barrel, Robinhood Markets, DuPont

BUZZ-U.S. STOCKS ON THE MOVE-Cracker Barrel, Robinhood Markets, DuPont Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were little changed on Friday as investors took a breather from the week's rally driven by growing expectations of U.S.
A
C
C
G
R
S
A
L
T
U
U
U
A
D
L
Reuters - Il y a 2 mois

U.S. STOCKS Tilray Brands, Arbutus Biopharma, Coinbase

BUZZ-U.S. STOCKS ON THE MOVE-Tilray Brands, Arbutus Biopharma, Coinbase Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were little changed on Friday as investors took a breather from the week's rally driven by growing expectations of U.S.
A
C
C
E
G
M
N
R
S
A
T
U
U
U
A
D
L
Reuters - Il y a 2 mois

U.S. STOCKS Advanced Micro Devices, United Airlines, GameStop

BUZZ-U.S. STOCKS ON THE MOVE-Advanced Micro Devices, United Airlines, GameStop Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were set to open marginally higher on Friday, looking to extend this week's rally on growing expectations of U.S.
A
G
M
N
R
A
T
U
U
A
D
L
Reuters - Il y a 2 mois

U.S. STOCKS DXC Technology, Darden Restaurants, Doximity

BUZZ-U.S. STOCKS ON THE MOVE-DXC Technology, Darden Restaurants, Doximity Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures were treading water on Friday, signaling a pause on Wall Street after a rally driven by expectations of interest-rate cuts this year.
A
C
G
R
T
U
D
L
Reuters - Il y a 2 mois

Ascension hack could be 'somewhat disruptive' for LabCorp, brokerage says

BUZZ-Ascension hack could be 'somewhat disruptive' for LabCorp, brokerage says ** Brokerage Evercore ISI says size and duration of a recent cyberattack at hospital operator Ascension could be "somewhat disruptive" for LabCorp LH.N in 2024 ** Evercore estimates that the non-profit hospital operator will contribute about $600 mln revenue to LH in 202
L
Reuters - Il y a 2 mois

Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy

BRIEF-Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy May 15 (Reuters) - Laboratory Corporation of America Holdings LH.N : LABCORP INTRODUCES FIRST TRIMESTER SCREENING TEST TO ASSESS PREECLAMPSIA RISK DURING PREGNANCY Source text for Eikon: ID:nPnZ1S6Ta Further company coverage: LH.N
L
Reuters - Il y a 2 mois

Invitae Receives Court Approval For Sale To Labcorp

BRIEF-Invitae Receives Court Approval For Sale To Labcorp May 7 (Reuters) - Labcorp and Invitae: INVITAE RECEIVES COURT APPROVAL FOR SALE TO LABCORP LABCORP - LABCORP WILL ACQUIRE SELECT ASSETS OF INVITAE ON A GOING CONCERN BASIS FOR $239 MILLION LABCORP - INVITAE AND LABCORP ANTICIPATE SALE WILL BE COMPLETED IN Q3 OF 2024 Source text for Eikon: ID
L
Reuters - Il y a 3 mois

US FDA tightens scrutiny of lab-developed tests with new rule

UPDATE 3-US FDA tightens scrutiny of lab-developed tests with new rule adds FDA executive comments in paragraphs 4-5, analyst comments in paragraph 10-11 April 29 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday tightened regulations for clinical laboratories with a new rule that gives it more oversight of diagnostic tests developed by them.
L
Reuters - Il y a 3 mois

US FDA publishes final rule for laboratory developed tests

US FDA publishes final rule for laboratory developed tests April 29 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday published the final rule to ensure safety and effectiveness of laboratory developed tests (LDTs), which are designed, manufactured and used within a clinical laboratory. Reporting by Mariam Sunny in Bengaluru; Editin
L
Reuters - Il y a 3 mois

Labcorp Receives FDA Approval For First Companion Diagnostic For Use With Pfizer's Newly Approved Gene Therapy To Treat Patients With Hemophilia B

BRIEF-Labcorp Receives FDA Approval For First Companion Diagnostic For Use With Pfizer's Newly Approved Gene Therapy To Treat Patients With Hemophilia B April 29 (Reuters) - Laboratory Corporation of America Holdings LH.N : LABCORP RECEIVES FDA APPROVAL FOR FIRST COMPANION DIAGNOSTIC FOR USE WITH PFIZER'S NEWLY APPROVED GENE THERAPY TO TREAT PATIEN
L
Reuters - Il y a 3 mois

U.S. STOCKS Loar, Regeneron, Intel

BUZZ-U.S. STOCKS ON THE MOVE-Loar, Regeneron, Intel Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stocks slumped on Thursday as most megacaps fell after Meta Platforms' quarterly results, while sentiment was shaken amid signs of persistent inflation that dampened hopes of the Federal Reserve easing monetary policy anytime soon.
A
B
B
B
C
C
G
I
M
N
N
P
R
T
L
T
U
U
D
R
S
T
W
C
D
L
T
Reuters - Il y a 3 mois

Labcorp falls on weak forecast for life sciences unit

BUZZ-Labcorp falls on weak forecast for life sciences unit ** Laboratory services provider Labcorp's LH.N shares fall as much as 5.7% to near six-month low of $196.11 ** Company's Q1 adj EPS of $3.68 beats est of $3.48 - LSEG ** Labcorp's weaker forecast for its life sciences unit, namely continued high cancellations faced by its early development services for drugs, could be weighing on shares - brokerage Baird ** Shares move in line with SPDR S&P Biotech ETF's XBI.P moves, which is down 2.8% -
L
Reuters - Il y a 3 mois

Laboratory Corporation of America Holdings reports results for the quarter ended in March - Earnings Summary

Laboratory Corporation of America Holdings reports results for the quarter ended in March - Earnings Summary Laboratory Corporation of America Holdings LH.N reported quarterly adjusted earnings of $3.68​​ per share for the quarter ended in March, lower than the same quarter last year, when the company reported EPS of $3.82. The mean expectation of sixteen analysts for the quarter was for earnings of $3.48 per share.
L
Reuters - Il y a 3 mois

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: EPH, Shareholder Capital, GTCR, DMCI Holdings, Updates: BHP Group April 25 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday: ** BHP Group BHP.AX bid $38.8 billion for Anglo American AAL.L , offering a deal to forge the world's biggest copper miner and driving its smaller rival's shares 13% higher.
C
C
C
A
L

Conditions

Actifs populaires

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques